Genentech H-1B Visa Sponsorship 2026
Pharma & biotech Β· H-1B sponsor Β· FY2017β2026
π’ South San Francisco, CA HQπ gene.com
Does Genentech sponsor H-1B visas and green cards?
Yes. Genentech has filed 1,679 H-1B LCAs and 342 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025β2026 Genentech filed 333 H-1B LCAs at a median base salary of $141,500, about 16% above the national H-1B median of $121,966 for the same period, and 57 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 171 | $141k |
| FY2025 | 162 | $142k |
| FY2024 | 155 | $143k |
| FY2023 | 155 | $141k |
| FY2022 | 182 | $130k |
| FY2021 | 126 | $124k |
| FY2020 | 166 | $119k |
| FY2019 | 194 | $115k |
| FY2018 | 157 | $107k |
| FY2017 | 211 | $104k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year β
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 23 | $171k |
| FY2025 | 34 | $183k |
| FY2024 | 25 | $178k |
| FY2023 | 30 | $178k |
| FY2022 | 29 | $164k |
| FY2021 | 22 | $144k |
| FY2020 | 34 | $156k |
| FY2019 | 33 | $143k |
| FY2018 | 64 | $133k |
| FY2017 | 48 | $127k |
Green-card route and outcomes
Worker backgrounds Β· FY2017β2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 3,423
- US patents
- Published, not yet granted
- 5,907
- applications
- Most recent grant
- April 7, 2026
- Top area
- Peptides1,829
Pay against the local market
Genentechβs 10 most-filed occupations and metros. Its median base salary is 100% of the local BLS median for the same work.
| Occupation | Metro | Filings | Genentech pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Statisticians | San Francisco, CA | 201 | $116,741 | $131,959 | 88% |
| Biological Scientists, All Other | San Francisco, CA | 166 | $107,932 | $118,454 | 91% |
| Medical Scientists | San Francisco, CA | 160 | $124,548 | $126,545 | 98% |
| Market Research Analysts and Marketing Specialists | San Francisco, CA | 123 | $127,619 | $99,983 | 128% |
| Computer Systems Analysts | San Francisco, CA | 81 | $136,448 | $130,707 | 104% |
| Software Developers | San Francisco, CA | 68 | $154,130 | $155,984 | 99% |
| Biochemists and Biophysicists | San Francisco, CA | 67 | $108,910 | $125,370 | 87% |
| Chemists | San Francisco, CA | 66 | $116,109 | $112,977 | 103% |
| Data Scientists | San Francisco, CA | 63 | $162,373 | $165,617 | 98% |
| Marketing Managers | San Francisco, CA | 52 | $159,948 | $184,046 | 87% |
About Genentech
Genentech is a pharma & biotech company based in South San Francisco, CA. It was founded in 1976 and has about 14,815 employees worldwide.
- Name (DOL filings)
- Genentech
- Founded
- 1976
- Sponsoring since
- FY2017 or earlier
- Headquarters
- South San Francisco, United States
- Industry
- Pharma & biotech
- Employees (US, est)
- 21,619 (2024)
- H-1B filings
- 1,679
- Median base
- $123,200
- Website
- gene.com
Genentech pays a median H-1B base of $123,200 across FY2017β2026, about 15% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Genentech
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Massachusetts General Hospital | 2,928 | 639 | $85k | 318 | 15% |
| IQVIA | 2,827 | 464 | $142k | 97 | 48% |
| Memorial Sloan Kettering Cancer Center | 2,624 | 432 | $85k | 184 | 35% |
| Genentech | 1,679 | 333 | $142k | 103 | 56% |
| Eli Lilly | 1,620 | 848 | $136k | 353 | 73% |
| Bayer | 1,604 | 335 | $140k | 87 | 87% |
| Regeneron | 1,497 | 505 | $155k | 147 | 41% |
